Overview
Cortagen is a synthetic tetrapeptide (Ala-Glu-Asp-Pro) characterized as a cortex cytoprotective peptide in research from the St. Petersburg Institute. It penetrates the blood-brain barrier and is reported to regulate neuronal gene expression, protect cortical neurons, and improve cognitive function in aging models. It is often studied alongside other peptide bioregulators from the same research group.
Routes of Administration
Standard research route
Research Profile
Mechanism of Action
Pharmacokinetics
Key Research Findings
Side Effects & Safety
Research Search Terms
Links open PubMed searches for peer-reviewed studies on this peptide.
Frequently Asked Questions
Cortagen is a synthetic tetrapeptide (Ala-Glu-Asp-Pro) characterized as a cortex cytoprotective peptide in research from the St. Petersburg Institute. It penetrates the blood-brain barrier and is reported to regulate neuronal gene expression, protect cortical neurons, and improve cognitive function in aging models. It is often studied alongside other peptide bioregulators from the same research group.
The reported half-life of Cortagen is Short; effects studied under cyclic protocols. Half-life refers to the time required for the plasma concentration to decrease by half through metabolic clearance.
In research settings, Cortagen is typically administered via: subcutaneous. Route selection affects onset, bioavailability, and duration of action.
Cortagen is currently at the Preclinical research — studied in cell cultures and animal models, with no approved human clinical trials. stage.
Cortagen profiles on Peptide United are for research and educational purposes only. This compound is not approved for human therapeutic use unless specifically noted. Always consult a qualified healthcare professional.
Related Compounds